Medline Industries Recall of NAMIC Angiographic Syringes
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Medline Industries, LP is recalling over 2.6 million units of various NAMIC Angiographic Syringes due to a potential risk of the syringe adaptor unwinding, which could cause disconnections during use.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 22, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly FDA detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action, a single localized FDA recall is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.
For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (recall, product-safety, fda, Devices) map to related alerts in the same area of risk - browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.
Medline Industries Recall of NAMIC Angiographic Syringes
What Happened
Medline Industries, LP has initiated a recall of certain NAMIC Angiographic Syringes due to a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.
Which Products Are Affected
The affected products include the following NAMIC Angiographic Syringes with specific Medline SKUs: 1. SYRINGE,20ML,CONTROL,-,PKG (SKU 70075027); 2. SYRINGE,10ML,TR/FR,RA,W/RES (SKU 70085007); 3. MTO,SYRINGE,10ML,TR/FG,RA,-,PKG (SKU 70085107); 4. SYRINGE,12ML,TR/FR,RA,W/RES (SKU 70087007); 5. MTO,SYRINGE,12ML,TR/FG,RA,W/RES (SKU 70087107); 6. SYRINGE,12ML,TR/FR,RA,W/O,RES,-,PKG (SKU 70088007); 7. SYRINGE,10ML,PP/FR,RA,-,PKG (SKU 70095007); 8. SYRINGE,10ML,PP/FG,RA,-,PKG (SKU 70095107); 9. SYRINGE,12ML,W/RES,PP/FR,RA,PG (SKU 70097007); 10. SYRINGE,12ML,PP/FG,RA,W/RES,-,PKG (SKU 70097107); 11. SYRINGE,12ML,PP/FG,RA,W/O,RES (SKU 70098107); 12. SYRINGE,20ML,TR/FR,RA,OEM,PG (SKU 80075027); 13. SYRINGE,10ML,ANGIO,W/RA,-,OEM (SKU 80085007); 14. SYRINGE,12ML,TR/FR,RA,OEM (SKU 80087007); 15. SYRINGE,10ML,PP/FR,RA,-,OEM,-,PG (SKU 80095007); 16. SYRINGE,10ML,PP/FG,RA,OEM,PG (SKU 80095107); 17. SYRINGE,12ML,PP/FG,RA,-,OEM,-,PG (SKU 80097107). Each product has associated UDI/DI numbers and specific lot numbers as listed in the recall notice. A total of 2,630,369 units are affected, distributed nationwide in the United States, including Puerto Rico, and to countries such as Canada, Netherlands, Australia, and others. The official recall number is Z-1712-2026.
What You Should Do
Consumers and users should follow the initial firm notification, which may include email, fax, letter, press release, telephone, or visit, to receive instructions from Medline Industries, LP regarding the affected products. Contact the firm for details on returns or refunds.
Why This Matters
This recall is classified as Class I by the FDA, indicating a high risk of serious adverse health consequences due to potential disconnections during medical procedures. It affects a large number of medical devices, underscoring the importance of ensuring product safety in healthcare settings.
Source
FDA Recall Number Z-1712-2026. Attribution: U.S. Food and Drug Administration (FDA). For more information, visit the FDA website at https://www.fda.gov/.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.